Patients who are on GLP-1 medications and stop them generally regain a substantial amount of the weight that they lost.
At 12 mg, 100% of participants lost at least 5% of body weight and 83% lost at least 15%
Thats $16,200 per year or 30% of the average Americans annual salary
The more transformative development is the imminent patent expiry of semaglutide in India in 2026
A board-certified physician reviews your health history, goals, and prior treatment response before deciding whether a dual-pathway option is appropriate
Our pharmacists hold advanced certifications from the Professional Compounding Centers of America (PCCA) and the National Home Infusion Association (NHIA), and bring more than 27 years of hands-on experience in sterile compounding, GLP-1 and peptide therapy, bioidentical hormone replacement, and personalized medicine